title: Transplantation of Macaca cynomolgus iPS-derived hematopoietic cells in NSG immunodeficient mice.
authors.affiliation: CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France Université Paris 7, France.
authors.forename: Soumeya
authors.initials: S
authors.lastname: Abed
authors.affiliation: CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Department of Biochemistry, Faculty of Medicine Siriraj Hospital and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
authors.forename: Alisa
authors.initials: A
authors.lastname: Tubsuwan
authors.affiliation: CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Department of Biochemistry, Faculty of Medicine Siriraj Hospital and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
authors.forename: Porntip
authors.initials: P
authors.lastname: Chaichompoo
authors.affiliation: Division of Pediatric Hematology/Oncology, Children's Hospital Boston, and Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.
authors.forename: In Hyun
authors.initials: IH
authors.lastname: Park
authors.affiliation: CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France.
authors.forename: Alice
authors.initials: A
authors.lastname: Pailleret
authors.affiliation: CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm U967 - CEA / DSV / IRCM, Fontenay Aux Roses Cedex, France.
authors.forename: Aïssa
authors.initials: A
authors.lastname: Benyoucef
authors.affiliation: Hôpital Antoine Béclère, Service d'Histologie Embryologie Cytogénétique, "Assistance Publique - Hôpitaux de Paris", Clamart, France.
authors.forename: Lucie
authors.initials: L
authors.lastname: Tosca
authors.affiliation: CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France Université Paris 7, France.
authors.forename: Edouard
authors.initials: E
authors.lastname: De Dreuzy
authors.affiliation: Bluebirdbio, Cambridge, MA, USA.
authors.forename: Anais
authors.initials: A
authors.lastname: Paulard
authors.affiliation: CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France.
authors.forename: Marine
authors.initials: M
authors.lastname: Granger-Locatelli
authors.affiliation: CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France.
authors.forename: Francis
authors.initials: F
authors.lastname: Relouzat
authors.affiliation: CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Prost
authors.affiliation: Hôpital Antoine Béclère, Service d'Histologie Embryologie Cytogénétique, "Assistance Publique - Hôpitaux de Paris", Clamart, France.
authors.forename: Gerard
authors.initials: G
authors.lastname: Tachdjian
authors.affiliation: Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Department of Biochemistry, Faculty of Medicine Siriraj Hospital and Department of Pathobiology, Faculty of Science, Mahidol University, Bangkok, Thailand.
authors.forename: Suthat
authors.initials: S
authors.lastname: Fucharoen
authors.affiliation: Division of Pediatric Hematology/Oncology, Children's Hospital Boston, and Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.
authors.forename: George Q
authors.initials: GQ
authors.lastname: Daley
authors.affiliation: CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Payen
authors.affiliation: CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France.
authors.forename: Stany
authors.initials: S
authors.lastname: Chrétien
authors.affiliation: CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Genetics Division, Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA.
authors.forename: Philippe
authors.initials: P
authors.lastname: Leboulch
authors.affiliation: CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Université Paris Sud 11, France Inserm, Paris, France leila.maouche@inserm.fr.
authors.forename: Leïla
authors.initials: L
authors.lastname: Maouche-Chrétien
mesh_terms: D000818:Animals; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000378:metabolism; D016867:Immunocompromised Host; D057026:Induced Pluripotent Stem Cells / Q000166:cytology*; D008251:Macaca; D051379:Mice; D023421:Models, Animal
keywords: Engraftment of cy-iPSC-derived hematopoietic cells; Induced pluripotent stem cells; Nonhuman primate